Human RIG-I Antiviral Deficiency Caused by a Dominant-Negative Variant Locked in a Signaling-Inactive State
This study identifies a novel dominant-negative RIG-I variant (G731R) in a severe COVID-19 patient that locks the receptor in a signaling-inactive state by disrupting ATPase activity and preventing signaling domain exposure, thereby causing critical antiviral deficiency.